Pathogenic Variants in Genes Associated With Lung Adenocarcinoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16-85
SponsorOscar Gerardo Arrieta Rodríguez

About this trial

The goal of this observational study is to describe the prevalence of germ line-pathogenic variants in Mexican patients with lung adenocarcinoma.

The main questions it aims to answer are:

1. What is the prevalence of pathogenic variants in genes associated with lung adenocarcinoma in Mexican patients younger than fifty? 2. Which clinical-pathological characteristics are associated with germ-line pathogenic variants in patients with lung adenocarcinoma? 3. How actionable somatic mutations are associated with germ line-pathogenic variants of patients with lung adenocarcinoma?

Participants will be asked to sign an informed consent; after that, they will be instructed to donate 10 ml of peripheral blood by venipuncture in the morning and before the patient has taken morning medication and the first meal, following a period of 8-12 hr fasting.

Eligibility criteria

Qualifiers

Both sexes

≥ 16 years old, according the institutional protocols for new patients admittances.

histologically confirmed lung adenocarcinoma (LUAD)

Signed written informed consent form

Disqualifiers

A sample of peripheral blood that is not accessible.

Insufficient clinical pathological information in the electronic clinical record.

Withdrawal

Insufficient DNA quality and quantity for genomic sequencing analyses.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Oscar Gerardo Arrieta Rodríguez

Lead sponsor

Instituto Nacional de Cancerologia de Mexico

Sponsor institution